Echopixel, Inc.

Echopixel, Inc.

Private
Santa Clara, CaliforniaHealthcare & Life Scienceshttp://www.echopixeltech.com

Last Round

Accelerator

Jun 6, 2023

Total Funding Raised

$10.85M

Momentum Score

75 /100

Company Overview

Echopixel, Inc. is a medical technology company that develops and markets a 3D medical visualization software platform. Its flagship product, True 3D, transforms data from standard medical images like CT and MRI scans into interactive, 4D holographic digital twins of patient anatomy. This technology allows physicians to view, manipulate, and dissect patient-specific organs and tissues in an open 3D space without headgear, which aids in diagnosis, surgical planning, and intra-operative guidance. The company's software is FDA 510k cleared and is used by medical institutions for applications in areas such as congenital heart defects, structural heart procedures, and surgical planning for complex surgeries.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, AR/VR Experiences, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware + Subscription, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

holographic medical imagingmedical visualizationsurgical planning software3d medical imagingintraoperative guidancepatient-specific digital twinimage-guided surgery4d visualizationsurgical navigationFDA-cleared medical deviceglasses-free 3dDICOM visualizationcardiology softwareholographic therapy guidanceHTGmedical AR/VR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Echopixel, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Echopixel, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 6, 2023
Series AOct 19, 2017
SeedNov 4, 2013

Key People

Founding team and executive leadership

Sergio Aguirre

Founder CEO

Founding Team

Echopixel, Inc. Investors

Notable investors and investment history

InvestorRounds
MedTech InnovatorAccelerator
Intel CapitalSeries A
Aurus CapitalSeries A
Runa CapitalSeries A
Binomial VenturesSeries A
Harris & Harris GroupSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 13, 2026

    Monthly visitors grew 73% MoM, from 1.3K to 2.3K.

  • Apr 17, 2026

    Monthly visitors grew 1203% MoM, reaching 1.3K.

Echopixel, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Echopixel, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Echopixel, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSanta Clara, California
Employee Range16
Year Founded2012
Last FundingJun 6, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.